SUBSCRIBE
PARTNER WITH US
WRITE FOR US

25 September 2002

Home / September 25, 2002

Here’€™s why the MCC is reviewing nevirapine
Living with AIDS progamme 91

The outcome of the Medicines Control Council'€™s review of the prevention of mother to child HIV transmission drug, nevirapine, is expected to be announced before the end of this month. The review of the drug caused confusion and concern in medical circles and among HIV/AIDS lobby groups after a newspaper report in early August suggested that the MCC was planning to '€œban'€ nevirapine after a '€œsecret'€ meeting with the drug'€™s manufacturers, Boehringer-Ingelheim. But, in this report by Khopotso Bodibe of Health-e News Service, we discover that there has never been any intention to ban or de-register the PMTCT drug.
Read More » Here’€™s why the MCC is reviewing nevirapine
Living with AIDS progamme 91

‘€œMCC won’€™t deregister nevirapine, despite review’€ ‘€“ say aids activists (Part 3)
Living with AIDS programme 93

Over the last two weeks in our Living with AIDS slot, we have attempted to piece together the rationale behind the Medicines Control Council'€™s review of nevirapine, the drug used in 18 government pilot sites to help prevent HIV infected women from transmitting the virus on to their babies. In our final instalment we talk to AIDS activists who are confident that the drug '€“ hailed by campaigners, doctors, researchers and scientists around the world as a potential life-saver '€“ will not be de-registered. Khopotso Bodibe of Health-e News Service, reports.
Read More » ‘€œMCC won’€™t deregister nevirapine, despite review’€ ‘€“ say aids activists (Part 3)
Living with AIDS programme 93

HIV positive women find support in others they counsel
Living with AIDS programme 89

They say that it takes a thief to catch another thief. Conversely, when it comes to HIV it can be said that it is much easier for a person living with the HI-virus to convincingly offer counselling and support to a recently diagnosed individual, or to one another. Khopotso Bodibe of Health-e News Service, spent time with two AIDS counsellors at the clinic during a debriefing session and spoke with them about the benefits of giving their time to helping other HIV-infected women.
Read More » HIV positive women find support in others they counsel
Living with AIDS programme 89

Here’€™s why the MCC is reviewing nevirapine (Part 2)
Living with AIDS Programme 92

In order for the Medicines Control Council (MCC) to make its final decision on the continued use of nevirapine for the prevention of mother-to-child HIV transmission in South Africa, the National Institutes of Health in the United States has to furnish it with documents detailing the drug'€™s trials in Uganda between 1997 and 1999.
Read More » Here’€™s why the MCC is reviewing nevirapine (Part 2)
Living with AIDS Programme 92

HIV/AIDS sends doctors back to school
Living with AIDS programme 90

Over the two decades of its manifestation in sub-Saharan Africa, HIV/AIDS continues to point to a major barrier that has not been addressed. And that is the development of a network of clinicians who can properly diagnose AIDS related infections as well as treat the disease safely and effectively. To fill this gap in South Africa, the South African Medical Association, through its educational arm '€“ the Foundation for Professional Development '€“ has developed an HIV/AIDS Clinical Management Course. The course is aimed at equipping doctors with the knowledge and skills to deal with the challenge presented by HIV/AIDS. Khopotso Bodibe of Health-e News Service, reports.
Read More » HIV/AIDS sends doctors back to school
Living with AIDS programme 90

Newsletter Subscription

Enable Notifications OK No thanks